NASDAQ: VMETVersamet Royalties Corp Stock
$13.37+2.34 (+21.21%)
Updated Apr 20, 2026
Precious metal companies are trading... find out Why VMET Price Moved with a free WallStreetZen account
Why Price MovedVMET Price
$13.37
Fair Value Price
N/A
Market Cap
$1.25B
52 Week Low
$9.11
52 Week High
$13.73
P/E
60.77x
P/B
5.34x
P/S
N/A
PEG
N/A
Dividend Yield
N/A
Revenue
$34.76M
Earnings
$20.33M
Gross Margin
38.8%
Operating Margin
120.15%
Profit Margin
58.5%
Debt to Equity
0.79
Operating Cash Flow
$17M
Beta
1.14
Next Earnings
N/A
Ex-Dividend
N/A
Next Dividend
N/A
VMET Overview
Versamet Royalties Corp. engages in the business of acquiring and managing royalties, streams, and other similar interests on metals and mining operations and projects globally. It focuses on precious metals, copper, and other diversified metals. Its portfolio includes the Kolpa, Kiaka, and Greenstone projects. The company was founded on January 31, 2022 and is headquartered in Vancouver, Canada.
Zen Rating
Our proven quant model uses 115 proprietary factors, including AI, to determine VMET's potential to beat the market
- VMET doesn't meet the minimum data requirements for our proprietary Zen Ratings model. Learn more about Zen Ratings.
Zen Rating Component Grades
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Zen Rating uses advanced AI algorithms that detect subtle patterns in market data; it anticipates future trends that point to superior stock price results.
Industry: Gold
Industry Rating
B
VMET
RankedUnranked of 54
RankedUnranked of 54
Top Ranked Stocks in Industry
| Name / Ticker | Price | Zen Rating |
|---|---|---|
| $14.54 | A | |
| $33.27 | A | |
| $16.83 | A |
Be the first to know about important VMET news, forecast changes, insider trades & much more!
VMET News
Overview
Due Diligence Score
–
Industry Average (33)
You've viewed Due Diligence Score for 10/10 free stocks. Upgrade to Premium to see how VMET scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.
Due Diligence Checks
VMET is poor value based on its earnings relative to its share price (60.77x), compared to the US market average (30.75x)
P/E vs Market Valuation
VMET is poor value based on its earnings relative to its share price (60.77x), compared to the US Gold industry average (19.34x)
P/E vs Industry Valuation
VMET is poor value based... subscribe to Premium to read more.
P/B vs Industry Valuation
There are 30 more VMET due diligence checks available for Premium users.
Valuation
VMET price to earnings (PE)
For valuing profitable companies with steady earnings
Company
60.77x
Industry
19.34x
Market
30.75x
VMET is poor value based... subscribe to Premium to read more.
P/E vs Industry Valuation
VMET is poor value based... subscribe to Premium to read more.
P/E vs Market Valuation
VMET price to book (PB)
For valuing companies that are loss-making or have lots of physical asset
Company
5.34x
Industry
3.75x
VMET is poor value based... subscribe to Premium to read more.
P/B vs Industry Valuation
VMET's financial health
Profit margin
Revenue
$18.4M
Net Income
$15.1M
Profit Margin
82%
VMET's Earnings (EBIT) of $41.76M... subscribe to Premium to read more.
Interest Coverage Financials
VMET's profit margin has increased... subscribe to Premium to read more.
Profit Margin Growth Financials
Assets to liabilities
Assets
$418.0M
Liabilities
$184.1M
Debt to equity
0.79
VMET's short-term liabilities ($32.88M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
VMET's long-term liabilities ($151.17M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
VMET's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials
Cash flow
Operating
$9.7M
Investing
$790.0k
Financing
-$9.2M
VMET's operating cash flow ($16.95M)... subscribe to Premium to read more.
Debt Coverage Financials
VMET vs Gold Stocks
Versamet Royalties Stock FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.